Federal Agencies to Address Issue of Pharmaceuticals in Drinking Water
Agencies to share scientific data and information and coordinate potential future research
Pharmaceuticals and personal care products (PPCPs) are being discovered in U.S. waters at low concentrations. Pharmaceuticals refer to prescription and over-the-counter therapeutic drugs and veterinary drugs. Personal care products refer to products used for personal and cosmetic reasons, such as soaps, fragrances and cosmetics.
The U.S. Department of Agriculture, the U.S. Department of Health and Human Services, the U.S. Department of the Interior and the U.S. Environmental Protection Agency have agreed to improve coordination and collaboration on issues related to pharmaceuticals in drinking water through a new memorandum of understanding.
Under this agreement, federal agencies will share scientific data and information and coordinate potential future research on the presence of pharmaceuticals in drinking water, their sources and potential health effects. The agencies formulated the agreement in response to a recommendation by the Government Accountability Office in 2011.
The agencies are responding to the issues of PPCPs in water with a four-pronged strategy aimed at:
- Improving science;
- Improving public understanding;
- Identifying partnership and stewardship opportunities; and
- Taking regulatory action when appropriate.
Click here for more information on the agreement.
More Like This
- EPA Continues Work to Understand Potential Impacts of Pharmaceuticals in Water
- Illinois EPA Releases Final Report on Pharmaceuticals in Drinking Water Supplies
- New Technology Helps Keep Pharmaceuticals Out of Water Supply
- Waters Corp. Offers Complimentary Drinking Water Testing for Pharmaceuticals
- EPA to Expand Chemicals Testing for Endocrine Disruption